Authors


Cara Slaton, PharmD

Latest:

STAY PrEPARED: Understanding COVID-19 Pre-Exposure Prophylaxis

New therapeutics offer some hope in this emerging market.


Kayla Stover, PharmD, BCIDP, BCPS, FCCP, FIDSA

Latest:

Top 5 Tips for Teaching ID Learners

The latest article from SIDP offers a Top 5 list of how to precept a learner on an infectious disease rotation.


Brian Lu, PharmD

Latest:

Combination Antifungal for Invasive Mucormycosis: Yay or Nay?

There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.


Mollie Tucker, MD

Latest:

Mixed Fungal Brain Abscess

Clinicians review a patient case including diagnosis, treatment, and follow-up.


Zahra Qamar, MD; Steven F. Solga, MD; and Lisa A. Spacek, MD, PhD, FIDSA

Latest:

NAFLD Is Increasingly Affecting Patients With HIV

The prevalence of this disease in this patient population is much higher than in the general public.


Sonal Patel, PharmD, BCIDP

Latest:

SPREADing the Love: The Importance of Mentorship in Pharmacy

In the latest column from SIDP, the authors discuss having leaders to help navigate school and beyond.


Paul Benn, MB, ChB, FRCP, MFPM

Latest:

ViiV Healthcare Presents Potential Long-Acting HIV Therapies

Phase 1 data on VH184, a third-generation integrase strand transfer inhibitor, and VH499, a novel HIV-1 capsid inhibitor, highlighting their antiviral potency, safety profiles, and potential for long-acting injectable formulations.


Esther Esadah, PharmD

Latest:

The Role of Pharmacists in the World of Pediatric Antimicrobial Stewardship

The limitation in the number of pediatric-specific guidelines by professional organizations, and results from large randomized clinical trials, may place an additional emphasis on literature evaluation skills for pediatric ASP pharmacists.


Thomas Lodise, PharmD, PhD

Latest:

Advice for Physicians to Manage C. Difficile Infection (CDI)

Experts share advice for physicians taking care of patients with C. difficile infection (CDI).


Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc; and Ryan P. McNamara, PhD

Latest:

Influenza Vaccination With SARS-CoV-2 mRNA Booster Shots

Drs Jacinda Abdul-Mutakabbir, Madeline King, Rodney Rohde, and expert nurse practitioner Wendy Wright provide insight on receiving the influenza vaccine concurrently with the SARS-CoV-2 booster shot, and comment on data on immune responses from the Moderna and Pfizer/BioNTech vaccines.


Killian Meara

Latest:

Reducing Long COVID Symptoms by Way of Vaccination

Research finds that individuals who received a COVID-19 vaccine more recently were less likely to develop long COVID.


Isabella Ciccone, MPH

Latest:

What We Know But Still Have to Learn About Long COVID

Despite advances in understanding and treating Long COVID, many questions about its mechanisms, susceptibility, and varied recovery patterns remain unresolved, underscoring the need for continued research.


James M. Crosby, DO

Latest:

Exploring the Recently Approved and Upcoming Clostridioides difficile Therapeutics

This market has seen a flurry of activity, as shown by a review of the latest agents.


Shmuel Shoham, MD

Latest:

COVID-19 Convalescent Plasma: What Is Its Role in Therapy?

The key is using the right dose on the right patient at the right time.


Jianxiang Xia, MD

Latest:

INSTIs and Cardiovascular Outcomes: More Complexity

The significance of antiretroviral therapy (ART) has been a game changer for people living with HIV (PLWH). Still, there are some cardiovascular risks associated with different ART classes—particularly protease inhibitors (PIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and integrase strand transfer inhibitors (INSTIs). Authors review a piece in the literature around this area of study.


Aleena Issac, PharmD

Latest:

Treating Persistent Methicillin-susceptible Staphylococcus aureus (MSSA) Bacteremia

Emerging treatment options for patients with persistently positive blood cultures with Methicillin-Susceptible Staphylococcus aureus (MSSA).


Torey Roesch, MD

Latest:

A Review of the Currently Available Monoclonal Antibodies for COVID-19

Outside of vaccines, these underutilized therapies are the best defense against severe disease.


Heather Platt, MD

Latest:

European Commission Approves Merck's Capvaxive for Adult Pneumococcal Disease Prevention

New 21-valent conjugate vaccine authorized to combat invasive pneumococcal disease and pneumonia in individuals aged 18 and older.


Eric Gregory, PharmD, BCIDP

Latest:

Vancomycin AUC Implementation in Resource-Limited Settings and its Associated Difficulties

The latest article from SIDP illustrates the challenges of area under the curve (AUC) implementation and offers insights for strategies and resources to overcome them.


Moupali Das, MD, MPH

Latest:

Gilead's Once Yearly Lenacapavir Formulations Show Sustained Efficacy for HIV PrEP in Phase 1 Study

New pharmacokinetic data, shared by Moupali Das, MD, MPH, reveal long-lasting plasma concentrations, surpassing twice-yearly subcutaneous formulation for HIV prevention



Gavin H. Harris, MD

Latest:

Now is Not the Time for Funding Pauses, Cutting Ties With Health Organizations

Biocontainment, including the most recent threat of highly pathogenic avian influenza, demands we continue to finance research, and continue cooperation with important organizations like the WHO.


Alice Gallo De Moraes, MD

Latest:

Opposing Forces During COVID-19: Perspective From the ICU

Conflicting priorities of infection control, antimicrobial stewardship, and critical care make the management of sepsis secondary to SARS-CoV-2 infection challenging.


Daniel Escobar, MD

Latest:

Community-Acquired Candida Glabrata Empyema: An Atypical Diagnosis Not to Miss

Although this patient had none of these common risk factors associated with Candida empyema, she did have other factors predisposing her to fungal colonization and subsequent infection.


Carter Keller

Latest:

GigaGen Doses First Patient in Phase 1 Trial of GIGA-2339, a Potential Functional Cure for Chronic Hepatitis B

Combining over 1,000 human antibodies, GIGA-2339 aims to achieve viral clearance and activate the immune system, offering a potential solution where current therapies fall short of providing a cure.


Donald Alcendor, PhD

Latest:

COVID-19 Booster Shots and the Future

Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.


Katelyn Kennedy, PharmD

Latest:

Oral Carbapenems: Promise, Peril, and Pushbacks

Here is a review of the literature for this class of antibiotics.


Albert Bach, PharmD

Latest:

What’s New With Non–COVID-19 Vaccines

Although COVID-19 vaccination remains the primary focus for health care, other paramount vaccines need to be recognized. Here is a review.


Jina Saltzman, PA-C

Latest:

Lessons in Resilience: What HIV Teaches Us About COVID-19

Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.


Jonathan Alicea

Latest:

Still Learning: Optimizing the Diagnosis and Screening of Respiratory Viruses

While the COVID-19 pandemic has helped advance respiratory diagnostics and surveillance, there are still many gaps that remain across the spectrum of healthcare.

© 2025 MJH Life Sciences

All rights reserved.